Laura Mezquita

机构：Breast Cancer Research Foundation, Hospital Clínic de Barcelona, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Universitat de Barcelona · ORCID：0000-0003-0936-7338

发表论文 418 篇 · 总被引 16073 次 · h-index 47

代表论文

• Utilizing ctDNA to discover mechanisms of resistance to targeted therapies in patients with metastatic NSCLC: towards more informative trials (2025 · Nature Reviews Clinical Oncology · 被引 11)
• Immunotherapy beyond progression combined with platinum-based chemotherapy after primary resistance to first-line immunotherapy in patients with advanced NSCLC and PD-L1 ≥50% (2025 · ESMO Open · 被引 5)
• Comprehensive computational analysis via Adverse Outcome Pathways and Aggregate Exposure Pathways in exploring synergistic effects from radon and tobacco smoke on lung cancer (2025 · Frontiers in Public Health · 被引 4)
• Prevalence and characteristics of lung cancer in families harboring Pathogenic Germline Variants in cancer predisposing genes: A 20-year retrospective analysis (2025 · European Journal of Cancer · 被引 4)
• Safety and efficacy of lurbinectedin plus atezolizumab as second-line treatment for advanced small-cell lung cancer: Results of the 2SMALL phase 1/2 study (NCT04253145). (2025 · Journal of Clinical Oncology · 被引 4)
• Assessing brain metastasis response to immunotherapy: a pictorial review of atypical responses and intracranial adverse events (2025 · Insights into Imaging · 被引 3)